Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPULSE: Empagliflozin in stabilized patients hospitalized for acute heart failure
jRCT2080225273Phase 3Unknown
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2020
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Acute Heart Failure (AHF) comparing Empagliflozin arm with Placebo arm (2 arms). Status: unknown.
02
Drugs
empagliflozin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on jRCT2080225273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225273.